Lisdexamfetamine Dimesylate
NDC 0406-5113, Lisdexamfetamine Dimesylate, capsule, from SpecGx LLC.
- Product NDC
- 0406-5113
- Status
- Listed
- Labeler
- SpecGx LLC
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211840
- DEA schedule
- CII
curl https://api.healthcare.dev/v1/drugs/ndc/0406-5113 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LISDEXAMFETAMINE DIMESYLATE30 mg/1
Pharmacologic classes
Central Nervous System Stimulant [EPC]; Central Nervous System Stimulation [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0406-5113-01 | 00406511301 | 100 CAPSULE in 1 BOTTLE (0406-5113-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/806a1c15-0842-4787-b2ad-09a21fd96b37NADAC price for package 00406511301
GET /v1/drugs/nadac/00406511301
Use it
Look up 0406-5113 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0406-5113 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0406-5113. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.